The Institute is devastated to announce the news of the death of Professor Michael Wakelam, the Institute’s Director. Professor Wakelam died yesterday from respiratory complications arising from a suspected Covid-19 infection. Professor Wakelam joined the Babraham Institute as Director in 2007. As the Institute’s Director, Professor Wakelam brought a dedication to scientific expertise, both in creating and protecting the environment required for excellent science to happen, and in creating an environment that developed expertise and capabilities in each individual to allow them to achieve their best. He was passionately committed to providing an excellent training experience for the Institute’s PhD students. Michael was an active voice on the value of fundamental research and international science. His research passion was lipids (cellular fats) and the techniques used to study them, and he maintained a research lab and lipidomics facility at the Institute during his time as Director.
Read the news article in full at: https://www.babraham.ac.uk/news/2020/04/michael-wakelam-1955-2020
Michael obtained his BSc in Medical Biochemistry and PhD in Biochemistry from Birmingham University. Following post-docs at the University of Konstanz in Germany and Imperial College London (as a Beit Memorial Fellow) he was appointed to a Lectureship in Biochemistry at Glasgow University in 1985. In 1993 he moved back to Birmingham as Professor of Molecular Pharmacology in the Institute for Cancer Studies, before joining the Babraham Institute as Director in 2007. His research focuses upon lipid signalling and lipidomics.